Mapping Tumor Epitope Space by Direct Selection of Single-Chain Fv Antibody Libraries on Prostate Cancer Cells

Cancer Research

Volumn 64, Issue 2, 2004, Pages 704-710

  Liu, Bin ^a,b   Conrad, Fraser ^a   Cooperberg, Matthew R ^c   Kirpotin, Dmitri B ^d   Marks, James D ^a,b  

^a Department of Anesthesia ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; NANOPARTICLE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CANCER CELL CULTURE; CONTROLLED STUDY; CROSS REACTION; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; EPITOPE MAPPING; GENE LIBRARY; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; PHAGE DISPLAY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN ANALYSIS;

ANTIBODIES, NEOPLASM; CELL DIVISION; CELL LINE, TUMOR; ENDOCYTOSIS; EPITOPES; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MALE; PEPTIDE LIBRARY; PROSTATIC NEOPLASMS;

EID: 1642556761     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2732     Document Type: Article

References (38)

1. Carter, P. Improving the efficacy of antibody-based cancer therapies. Nat. Rev. Cancer, 1: 118-129, 2001.
2. Theocharis, A. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim. Biophys. Acta, 1588: 165-172, 2002.
3. M3-carbohydrate antigen. J. Am. Chem. Soc., 124: 12439-12446, 2002.
4. Fair, W. R., Israeli, R. S., and Heston, W. D. Prostate-specific membrane antigen. Prostate, 32: 140-148, 1997.
5. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., and Chinnaiyan, A. M. Delineation of prognostic biomarkers in prostate cancer. Nature (Lond.), 412: 822-826, 2001.
6. Xu, L. L., Stackhouse, B. G., Florence, K., Zhang, W., Shanmugam, N., Sesterhenn, I. A., Zhou, Z., Srikantan, V., Augustus, M., Roschke, V., Carter, K., McLeod, D. G., Moul, J. W., Soppett, D., and Srivastava, S. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res., 60: 6568-6572, 2000.
7. Hubert, R. S., Vivianco, I., Chen, E., Rastegar, S., Leong, K., Mitchell, S. C., Madraswala, R., Zhou, Y., Kuo, J., Raitano, A. B., Jakobovits, A., Saffran, D. C., and Afar, D. E. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc. Natl. Acad. Sci. USA, 96: 14523-14528, 1999.
8. Saffran, D. C., Raitano, A. B., Hubert, R. S., Witte, O. N., Reiter, R. E., and Jakobovits, A. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc. Natl. Acad. Sci. USA, 98: 2658-2663, 2001.
9. Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., Loda, M., and Witte, O. N. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA, 95: 1735-1740, 1998.
10. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M. J. Cancer statistics, 2003. CA Cancer J. Clin., 53: 5-26, 2003.
11. Coleman, R. E. Future directions in the treatment and prevention of bone metastases. Am J. Clin. Oncol., 25: S32-S38, 2002.
12. Marks, J. D., Hoogenboom, H., Bonnert, T., McCafferty, J., Griffiths, A., and Winter, G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol., 222: 581-597, 1991.
13. de Haard, H. J., van Neer, N., Reurs, A., Hufton, S. E., Roovers, R. C., Henderikx, P., de Bruine, A. P., Arends, J. W., and Hoogenboom, H. R. A. large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem., 274: 18218-18230, 1999.
14. McCafferty, J., Griffiths, A., Winter, G., and Chiswell, D. Phage antibodies: filamentous phage displaying antibody variable domains. Nature (Lond.), 348: 552-554, 1990.
15. Barbas, C. F., III, Kang, A. S., Lerner, R. A., and Benkovic, S. J. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. USA, 88: 7978-7982, 1991.
16. Sheets, M., Amersdorfer, P., Finnern, R., Sargent, P., Lindqvist, E., Schier, R., Hemingsen, G., Wong, C., Gerhart, J. C., and Marks, J. D. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc. Natl. Acad. Sci. USA, 95: 6157-6162, 1998.
17. Griffiths, A. D., Malmqvist, M., Marks, J. D., Bye, J. M., Embleton, M. J., McCafferty, J., Baier, M., Holliger, K. P., Gorick, B. D., Hughes-Jones, N. C., et al. Human anti-self antibodies with high specificity from phage display libraries. EMBO J., 12: 725-734, 1993.
18. Amersdorfer, P., Wong, C., Smith, T., Chen, S., Deshpande, S., Sheridan, R., and Marks, J. D. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries. Vaccine, 20: 1640-1648, 2002.
19. Hoogenboom, H. R. Overview of antibody phage-display technology and its applications. Methods Mol. Biol., 178: 1-37, 2002.
20. Gao, C., Mao, S., Ronca, F., Zhuang, S., Quaranta, V., Wirsching, P., and Janda, K. D. De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods. J. Immunol. Methods, 274: 185-197, 2003.
21. Becerril, B., Poul, M. A., and Marks, J. D. Toward selection of internalizing antibodies from phage libraries. Biochem. Biophys. Res. Commun., 255: 386-393, 1999.
22. Nielsen, U. B., Kirpotin, D. B., Pickering, E. M., Hong, K., Park, J. W., Refaat Shalaby, M., Shao, Y., Benz, C. C., and Marks, J. D. Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis. Biochim. Biophys. Acta, 1591: 109-118, 2002.
23. Poul, M. A., Becerril, B., Nielsen, U. B., Morisson, P., and Marks, J. D. Selection of tumor-specific internalizing human antibodies from phage libraries. J. Mol. Biol., 301: 1149-1161, 2000.
24. Heitner, T., Moor, A., Garrison, J. L., Marks, C. C., Hasan, T., and Marks, J. D. Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library. J. Immunol. Methods, 248: 17-30, 2001.
25. O'Connell, D., Becerril, B., Roy-Burman, A., Daws, M., and Marks, J. D. Phage versus phagemid libraries for generation of human monoclonal antibodies. J. Mol. Biol., 321: 49-56, 2002.
26. Liu, B., and Marks, J. D. Applying phage antibodies to proteomics: selecting single chain Fv antibodies to antigens blotted on nitrocellulose. Anal. Biochem., 286: 119-128, 2000.
27. Huie, M. A., Cheung, M. C., Muench, M. O., Becerril, B., Kan, Y. W., and Marks, J. D. Antibodies to human fetal erythroid cells from a nonimmune phage antibody library. Proc. Natl. Acad. Sci. USA, 98: 2682-2687, 2001.
28. Liu, B., Huang, L., Sihlbom, C., Burlingame, A., and Marks, J. D. Towards proteome-wide production of monoclonal antibody by phage display. J. Mol. Biol., 315: 1063-1073, 2002.
29. Adams, G. P., McCartney, J. E., Tai, M. S., Oppermann, H., Huston, J. S., Stafford, W. F., III, Bookman, M. A., Fand, I., Houston, L. L., and Weiner, L. M. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-cerbB-2 single-chain Fv. Cancer Res., 53: 4026-4034, 1993.
30. Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, R. D., Woodle, M. C., Lasic, D. D., Redemann, C., et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA, 88: 11460-11464, 1991.
31. Hayward, S. W., Dahiya, R., Cunha, G. R., Bartek, J., Deshpande, N., and Narayan, P. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev. Biol. Anim., 31: 14-24, 1995.
32. Watkins, S. J., and Norbury, C. J. Translation initiation and its deregulation during tumorigenesis. Br. J. Cancer, 86: 1023-1027, 2002.
33. Skubitz, A. Adhesion molecules. Cancer Treat. Res., 107: 305-329, 2002.
34. Cai, X., and Garen, A. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc. Natl. Acad. Sci. USA, 92: 6537-6541, 1995.
35. Li, J., Pereira, S., Van Belle, P., Tsui, P., Elder, D., Speicher, D., Deen, K., Linnenbach, A., Somasundaram, R., Swoboda, R., and Herlyn, D. Isolation of the melanoma-associated antigen p23 using antibody phage display. J. Immunol., 166: 432-438, 2001.
36. Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G., Otte, A. P., Rubin, M. A., and Chinnaiyan, A. M. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (Lond.), 419: 624-629, 2002.
37. Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G., Shalaby, R., Baselga, J., Shao, Y., Nielsen, U. B., Marks, J. D., Moore, D., Papahadjopoulos, D., and Benz, C. C. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002.
38. Cai, X., and Garen, A. A melanoma-specific VH antibody cloned from a fusion phage library of a vaccinated melanoma patient. Proc. Natl. Acad. Sci. USA, 93: 6280-6285, 1996.